 | • レポートコード：QAF27674 • 出版社/出版日：QYResearch / 2021年4月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、136ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の勃起不全治療薬市場について種類別（シルデナフィル、タダラフィル、その他）、用途別（病院薬局、民間クリニック、小売薬局、Eコマース（B2B）、Eコマース（B2C））、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・勃起不全治療薬市場の概要 ・世界の主要地域別勃起不全治療薬市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の勃起不全治療薬市場規模2016-2021：種類別（シルデナフィル、タダラフィル、その他） ・世界の勃起不全治療薬市場予測2012-2027：種類別（シルデナフィル、タダラフィル、その他） ・世界の勃起不全治療薬市場規模2016-2021：用途別（病院薬局、民間クリニック、小売薬局、Eコマース（B2B）、Eコマース（B2C）） ・世界の勃起不全治療薬市場予測2012-2027：用途別（病院薬局、民間クリニック、小売薬局、Eコマース（B2B）、Eコマース（B2C）） ・勃起不全治療薬のアメリカ市場規模と予測2016-2021 ・勃起不全治療薬のヨーロッパ市場規模と予測2016-2021 ・勃起不全治療薬の中国市場規模と予測2016-2021 ・勃起不全治療薬の日本市場規模と予測2016-2021 ・勃起不全治療薬の東南アジア市場規模と予測2016-2021 ・勃起不全治療薬のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Eli Lilly、Pfizer、Bayer、BaiYunShan General Factory、S.K. Chemicals、Teva Pharma、Dong-A ST、Metuchen Pharma、Seoul Pharma、CSBIO.） ・勃起不全治療薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・勃起不全治療薬の市場動向・機会・課題 ・調査の結論 |
Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
The classification of Erectile Dysfunction Drugs includes Sildenafil, Tadalafil and others, and the proportion of Sildenafil in 2018 is about 99.85%, and the proportion is in decreasing trend from 2014 to 2018.Erectile Dysfunction Drugs is widely used through Hospital Pharmacies, Private Clinics, Retail Pharmacies, E-Commerce (B2B) and E-Commerce (B2C). The most proportion of Erectile Dysfunction Drugs is used for Hospital Pharmacies, and the sales proportion in 2018 is 29.24%.North America is the largest consumption place, with a consumption market share nearly 39.05% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 30.52%. Despite of increasing demand for erectile dysfunction drugs, this market is going to experience a decline in forecast period due to patent expiration of major brands. On the contrary, it will provide the key opportunity for generic manufacturers to enter the market. Generic drugs are the promising opportunity for this market.
Market Analysis and Insights: Global Erectile Dysfunction Drugs Market
The global Erectile Dysfunction Drugs market was valued at US$ 6067.4 in 2020 and will reach US$ 8606.8 million by the end of 2027, growing at a CAGR of 6.0% during 2022-2027.
Global Erectile Dysfunction Drugs Scope and Market Size
The global Erectile Dysfunction Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Erectile Dysfunction Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Sildenafil
Tadalafil
Others
In 2018, Sildenafil accounted for a major share of 56% in the global Erectile Dysfunction Drugs market. And this product segment is poised to reach 3366.84 M USD by 2025 from 2483.77 M USD in 2019.
Segment by Application
Hospital Pharmacies
Private Clinics
Retail Pharmacies
E-Commerce (B2B)
E-Commerce (B2C)
In Erectile Dysfunction Drugs market, Hospital Pharmacies segment holds an important share in terms of application, and it is expected to reach a volume of 458.57 (M Pill) by 2025, at a CAGR of 12.63% during 2018 and 2025. It means that Erectile Dysfunction Drugs will be promising in the Hospital Pharmacies field in the next couple of years.
The Erectile Dysfunction Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Erectile Dysfunction Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Metuchen Pharma
Seoul Pharma
CSBIO.
1 Erectile Dysfunction Drugs Market Overview
1.1 Erectile Dysfunction Drugs Product Scope
1.2 Erectile Dysfunction Drugs Segment by Type
1.2.1 Global Erectile Dysfunction Drugs Sales by Type (2016 & 2021 & 2027)
1.2.2 Sildenafil
1.2.3 Tadalafil
1.2.4 Others
1.3 Erectile Dysfunction Drugs Segment by Application
1.3.1 Global Erectile Dysfunction Drugs Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital Pharmacies
1.3.3 Private Clinics
1.3.4 Retail Pharmacies
1.3.5 E-Commerce (B2B)
1.3.6 E-Commerce (B2C)
1.4 Erectile Dysfunction Drugs Market Estimates and Forecasts (2016-2027)
1.4.1 Global Erectile Dysfunction Drugs Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Erectile Dysfunction Drugs Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Erectile Dysfunction Drugs Price Trends (2016-2027)
2 Erectile Dysfunction Drugs Estimates and Forecasts by Region
2.1 Global Erectile Dysfunction Drugs Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Erectile Dysfunction Drugs Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Erectile Dysfunction Drugs Sales Market Share by Region (2016-2021)
2.2.2 Global Erectile Dysfunction Drugs Revenue Market Share by Region (2016-2021)
2.3 Global Erectile Dysfunction Drugs Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Erectile Dysfunction Drugs Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Erectile Dysfunction Drugs Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Erectile Dysfunction Drugs Estimates and Projections (2016-2027)
2.4.2 Europe Erectile Dysfunction Drugs Estimates and Projections (2016-2027)
2.4.3 China Erectile Dysfunction Drugs Estimates and Projections (2016-2027)
2.4.4 Japan Erectile Dysfunction Drugs Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Erectile Dysfunction Drugs Estimates and Projections (2016-2027)
2.4.6 India Erectile Dysfunction Drugs Estimates and Projections (2016-2027)
3 Global Erectile Dysfunction Drugs Competition Landscape by Players
3.1 Global Top Erectile Dysfunction Drugs Players by Sales (2016-2021)
3.2 Global Top Erectile Dysfunction Drugs Players by Revenue (2016-2021)
3.3 Global Erectile Dysfunction Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Erectile Dysfunction Drugs as of 2020)
3.4 Global Erectile Dysfunction Drugs Average Price by Company (2016-2021)
3.5 Manufacturers Erectile Dysfunction Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Erectile Dysfunction Drugs Market Size by Type
4.1 Global Erectile Dysfunction Drugs Historic Market Review by Type (2016-2021)
4.1.1 Global Erectile Dysfunction Drugs Sales Market Share by Type (2016-2021)
4.1.2 Global Erectile Dysfunction Drugs Revenue Market Share by Type (2016-2021)
4.1.3 Global Erectile Dysfunction Drugs Price by Type (2016-2021)
4.2 Global Erectile Dysfunction Drugs Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Erectile Dysfunction Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Erectile Dysfunction Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Global Erectile Dysfunction Drugs Price Forecast by Type (2022-2027)
5 Global Erectile Dysfunction Drugs Market Size by Application
5.1 Global Erectile Dysfunction Drugs Historic Market Review by Application (2016-2021)
5.1.1 Global Erectile Dysfunction Drugs Sales Market Share by Application (2016-2021)
5.1.2 Global Erectile Dysfunction Drugs Revenue Market Share by Application (2016-2021)
5.1.3 Global Erectile Dysfunction Drugs Price by Application (2016-2021)
5.2 Global Erectile Dysfunction Drugs Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Erectile Dysfunction Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Erectile Dysfunction Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Erectile Dysfunction Drugs Price Forecast by Application (2022-2027)
6 North America Erectile Dysfunction Drugs Market Facts & Figures
6.1 North America Erectile Dysfunction Drugs Sales by Company
6.1.1 North America Erectile Dysfunction Drugs Sales by Company (2016-2021)
6.1.2 North America Erectile Dysfunction Drugs Revenue by Company (2016-2021)
6.2 North America Erectile Dysfunction Drugs Sales Breakdown by Type
6.2.1 North America Erectile Dysfunction Drugs Sales Breakdown by Type (2016-2021)
6.2.2 North America Erectile Dysfunction Drugs Sales Breakdown by Type (2022-2027)
6.3 North America Erectile Dysfunction Drugs Sales Breakdown by Application
6.3.1 North America Erectile Dysfunction Drugs Sales Breakdown by Application (2016-2021)
6.3.2 North America Erectile Dysfunction Drugs Sales Breakdown by Application (2022-2027)
7 Europe Erectile Dysfunction Drugs Market Facts & Figures
7.1 Europe Erectile Dysfunction Drugs Sales by Company
7.1.1 Europe Erectile Dysfunction Drugs Sales by Company (2016-2021)
7.1.2 Europe Erectile Dysfunction Drugs Revenue by Company (2016-2021)
7.2 Europe Erectile Dysfunction Drugs Sales Breakdown by Type
7.2.1 Europe Erectile Dysfunction Drugs Sales Breakdown by Type (2016-2021)
7.2.2 Europe Erectile Dysfunction Drugs Sales Breakdown by Type (2022-2027)
7.3 Europe Erectile Dysfunction Drugs Sales Breakdown by Application
7.3.1 Europe 136 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 136 Sales Breakdown by Application (2022-2027)
8 China Erectile Dysfunction Drugs Market Facts & Figures
8.1 China Erectile Dysfunction Drugs Sales by Company
8.1.1 China Erectile Dysfunction Drugs Sales by Company (2016-2021)
8.1.2 China Erectile Dysfunction Drugs Revenue by Company (2016-2021)
8.2 China Erectile Dysfunction Drugs Sales Breakdown by Type
8.2.1 China Erectile Dysfunction Drugs Sales Breakdown by Type (2016-2021)
8.2.2 China Erectile Dysfunction Drugs Sales Breakdown by Type (2022-2027)
8.3 China Erectile Dysfunction Drugs Sales Breakdown by Application
8.3.1 China 247 Sales Breakdown by Application (2016-2021)
8.3.2 China 247 Sales Breakdown by Application (2022-2027)
9 Japan Erectile Dysfunction Drugs Market Facts & Figures
9.1 Japan Erectile Dysfunction Drugs Sales by Company
9.1.1 Japan Erectile Dysfunction Drugs Sales by Company (2016-2021)
9.1.2 Japan Erectile Dysfunction Drugs Revenue by Company (2016-2021)
9.2 Japan Erectile Dysfunction Drugs Sales Breakdown by Type
9.2.1 Japan Erectile Dysfunction Drugs Sales Breakdown by Type (2016-2021)
9.2.2 Japan Erectile Dysfunction Drugs Sales Breakdown by Type (2022-2027)
9.3 Japan Erectile Dysfunction Drugs Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Erectile Dysfunction Drugs Market Facts & Figures
10.1 Southeast Asia Erectile Dysfunction Drugs Sales by Company
10.1.1 Southeast Asia Erectile Dysfunction Drugs Sales by Company (2016-2021)
10.1.2 Southeast Asia Erectile Dysfunction Drugs Revenue by Company (2016-2021)
10.2 Southeast Asia Erectile Dysfunction Drugs Sales Breakdown by Type
10.2.1 Southeast Asia Erectile Dysfunction Drugs Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Erectile Dysfunction Drugs Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Erectile Dysfunction Drugs Sales Breakdown by Application
10.3.1 Southeast Asia M Pill Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia M Pill Sales Breakdown by Application (2022-2027)
11 India Erectile Dysfunction Drugs Market Facts & Figures
11.1 India Erectile Dysfunction Drugs Sales by Company
11.1.1 India Erectile Dysfunction Drugs Sales by Company (2016-2021)
11.1.2 India Erectile Dysfunction Drugs Revenue by Company (2016-2021)
11.2 India Erectile Dysfunction Drugs Sales Breakdown by Type
11.2.1 India Erectile Dysfunction Drugs Sales Breakdown by Type (2016-2021)
11.2.2 India Erectile Dysfunction Drugs Sales Breakdown by Type (2022-2027)
11.3 India Erectile Dysfunction Drugs Sales Breakdown by Application
11.3.1 India Erectile Dysfunction Drugs Sales Breakdown by Application (2016-2021)
11.3.2 India Erectile Dysfunction Drugs Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Erectile Dysfunction Drugs Business
12.1 Eli Lilly
12.1.1 Eli Lilly Corporation Information
12.1.2 Eli Lilly Business Overview
12.1.3 Eli Lilly Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Eli Lilly Erectile Dysfunction Drugs Products Offered
12.1.5 Eli Lilly Recent Development
12.2 Pfizer
12.2.1 Pfizer Corporation Information
12.2.2 Pfizer Business Overview
12.2.3 Pfizer Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Pfizer Erectile Dysfunction Drugs Products Offered
12.2.5 Pfizer Recent Development
12.3 Bayer
12.3.1 Bayer Corporation Information
12.3.2 Bayer Business Overview
12.3.3 Bayer Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Bayer Erectile Dysfunction Drugs Products Offered
12.3.5 Bayer Recent Development
12.4 BaiYunShan General Factory
12.4.1 BaiYunShan General Factory Corporation Information
12.4.2 BaiYunShan General Factory Business Overview
12.4.3 BaiYunShan General Factory Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 BaiYunShan General Factory Erectile Dysfunction Drugs Products Offered
12.4.5 BaiYunShan General Factory Recent Development
12.5 S.K. Chemicals
12.5.1 S.K. Chemicals Corporation Information
12.5.2 S.K. Chemicals Business Overview
12.5.3 S.K. Chemicals Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 S.K. Chemicals Erectile Dysfunction Drugs Products Offered
12.5.5 S.K. Chemicals Recent Development
12.6 Teva Pharma
12.6.1 Teva Pharma Corporation Information
12.6.2 Teva Pharma Business Overview
12.6.3 Teva Pharma Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Teva Pharma Erectile Dysfunction Drugs Products Offered
12.6.5 Teva Pharma Recent Development
12.7 Dong-A ST
12.7.1 Dong-A ST Corporation Information
12.7.2 Dong-A ST Business Overview
12.7.3 Dong-A ST Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Dong-A ST Erectile Dysfunction Drugs Products Offered
12.7.5 Dong-A ST Recent Development
12.8 Metuchen Pharma
12.8.1 Metuchen Pharma Corporation Information
12.8.2 Metuchen Pharma Business Overview
12.8.3 Metuchen Pharma Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Metuchen Pharma Erectile Dysfunction Drugs Products Offered
12.8.5 Metuchen Pharma Recent Development
12.9 Seoul Pharma
12.9.1 Seoul Pharma Corporation Information
12.9.2 Seoul Pharma Business Overview
12.9.3 Seoul Pharma Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Seoul Pharma Erectile Dysfunction Drugs Products Offered
12.9.5 Seoul Pharma Recent Development
12.10 CSBIO.
12.10.1 CSBIO. Corporation Information
12.10.2 CSBIO. Business Overview
12.10.3 CSBIO. Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 CSBIO. Erectile Dysfunction Drugs Products Offered
12.10.5 CSBIO. Recent Development
13 Erectile Dysfunction Drugs Manufacturing Cost Analysis
13.1 Erectile Dysfunction Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Erectile Dysfunction Drugs
13.4 Erectile Dysfunction Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Erectile Dysfunction Drugs Distributors List
14.3 Erectile Dysfunction Drugs Customers
15 Market Dynamics
15.1 Erectile Dysfunction Drugs Market Trends
15.2 Erectile Dysfunction Drugs Drivers
15.3 Erectile Dysfunction Drugs Market Challenges
15.4 Erectile Dysfunction Drugs Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Erectile Dysfunction Drugs Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Erectile Dysfunction Drugs Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Erectile Dysfunction Drugs Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Erectile Dysfunction Drugs Sales (M Pill) by Region (2016-2021)
Table 5. Global Erectile Dysfunction Drugs Sales Market Share by Region (2016-2021)
Table 6. Global Erectile Dysfunction Drugs Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Erectile Dysfunction Drugs Revenue Share by Region (2016-2021)
Table 8. Global Erectile Dysfunction Drugs Sales (M Pill) Forecast by Region (2022-2027)
Table 9. Global Erectile Dysfunction Drugs Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Erectile Dysfunction Drugs Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Erectile Dysfunction Drugs Revenue Share Forecast by Region (2022-2027)
Table 12. Global Erectile Dysfunction Drugs Sales (M Pill) of Key Companies (2016-2021)
Table 13. Global Erectile Dysfunction Drugs Sales Share by Company (2016-2021)
Table 14. Global Erectile Dysfunction Drugs Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Erectile Dysfunction Drugs Revenue Share by Company (2016-2021)
Table 16. Global Erectile Dysfunction Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Erectile Dysfunction Drugs as of 2020)
Table 17. Global Erectile Dysfunction Drugs Average Price (USD/Pill) of Key Company (2016-2021)
Table 18. Manufacturers Erectile Dysfunction Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Erectile Dysfunction Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Erectile Dysfunction Drugs Sales (M Pill) by Type (2016-2021)
Table 22. Global Erectile Dysfunction Drugs Sales Share by Type (2016-2021)
Table 23. Global Erectile Dysfunction Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Erectile Dysfunction Drugs Price (USD/Pill) by Type (2016-2021)
Table 25. Global Erectile Dysfunction Drugs Sales Share by Type (2022-2027)
Table 26. Global Erectile Dysfunction Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Erectile Dysfunction Drugs Revenue Share by Type (2022-2027)
Table 28. Global Erectile Dysfunction Drugs Price (USD/Pill) by Type (2022-2027)
Table 29. Global Erectile Dysfunction Drugs Sales (M Pill) by Application (2016-2021)
Table 30. Global Erectile Dysfunction Drugs Sales Share by Application (2016-2021)
Table 31. Global Erectile Dysfunction Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Erectile Dysfunction Drugs Price (USD/Pill) by Application (2016-2021)
Table 33. Global Erectile Dysfunction Drugs Sales (M Pill) by Application (2022-2027)
Table 34. Global Erectile Dysfunction Drugs Sales Share by Application (2022-2027)
Table 35. Global Erectile Dysfunction Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Erectile Dysfunction Drugs Revenue Share by Application (2022-2027)
Table 37. Global Erectile Dysfunction Drugs Price (USD/Pill) by Application (2022-2027)
Table 38. North America Erectile Dysfunction Drugs Sales (M Pill) by Company (2016-2021)
Table 39. North America Erectile Dysfunction Drugs Sales Market Share by Company (2016-2021)
Table 40. North America Erectile Dysfunction Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Erectile Dysfunction Drugs Revenue Market Share by Company (2016-2021)
Table 42. North America Erectile Dysfunction Drugs Sales by Type (2016-2021) & (M Pill)
Table 43. North America Erectile Dysfunction Drugs Sales Market Share by Type (2016-2021)
Table 44. North America Erectile Dysfunction Drugs Sales by Type (2022-2027) & (M Pill)
Table 45. North America Erectile Dysfunction Drugs Sales Market Share by Type (2022-2027)
Table 46. North America Erectile Dysfunction Drugs Sales by Application (2016-2021) & (M Pill)
Table 47. North America Erectile Dysfunction Drugs Sales Market Share by Application (2016-2021)
Table 48. North America Erectile Dysfunction Drugs Sales by Application (2022-2027) & (M Pill)
Table 49. North America Erectile Dysfunction Drugs Sales Market Share by Application (2022-2027)
Table 50. Europe Erectile Dysfunction Drugs Sales (M Pill) by Company (2016-2021)
Table 51. Europe Erectile Dysfunction Drugs Sales Market Share by Company (2016-2021)
Table 52. Europe Erectile Dysfunction Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Erectile Dysfunction Drugs Revenue Market Share by Company (2016-2021)
Table 54. Europe Erectile Dysfunction Drugs Sales by Type (2016-2021) & (M Pill)
Table 55. Europe Erectile Dysfunction Drugs Sales Market Share by Type (2016-2021)
Table 56. Europe Erectile Dysfunction Drugs Sales by Type (2022-2027) & (M Pill)
Table 57. Europe Erectile Dysfunction Drugs Sales Market Share by Type (2022-2027)
Table 58. Europe Erectile Dysfunction Drugs Sales by Application (2016-2021) & (M Pill)
Table 59. Europe Erectile Dysfunction Drugs Sales Market Share by Application (2016-2021)
Table 60. Europe Erectile Dysfunction Drugs Sales by Application (2022-2027) & (M Pill)
Table 61. Europe Erectile Dysfunction Drugs Sales Market Share by Application (2022-2027)
Table 62. China Erectile Dysfunction Drugs Sales (M Pill) by Company (2016-2021)
Table 63. China Erectile Dysfunction Drugs Sales Market Share by Company (2016-2021)
Table 64. China Erectile Dysfunction Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Erectile Dysfunction Drugs Revenue Market Share by Company (2016-2021)
Table 66. China Erectile Dysfunction Drugs Sales by Type (2016-2021) & (M Pill)
Table 67. China Erectile Dysfunction Drugs Sales Market Share by Type (2016-2021)
Table 68. China Erectile Dysfunction Drugs Sales by Type (2022-2027) & (M Pill)
Table 69. China Erectile Dysfunction Drugs Sales Market Share by Type (2022-2027)
Table 70. China Erectile Dysfunction Drugs Sales by Application (2016-2021) & (M Pill)
Table 71. China Erectile Dysfunction Drugs Sales Market Share by Application (2016-2021)
Table 72. China Erectile Dysfunction Drugs Sales by Application (2022-2027) & (M Pill)
Table 73. China Erectile Dysfunction Drugs Sales Market Share by Application (2022-2027)
Table 74. Japan Erectile Dysfunction Drugs Sales (M Pill) by Company (2016-2021)
Table 75. Japan Erectile Dysfunction Drugs Sales Market Share by Company (2016-2021)
Table 76. Japan Erectile Dysfunction Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Erectile Dysfunction Drugs Revenue Market Share by Company (2016-2021)
Table 78. Japan Erectile Dysfunction Drugs Sales by Type (2016-2021) & (M Pill)
Table 79. Japan Erectile Dysfunction Drugs Sales Market Share by Type (2016-2021)
Table 80. Japan Erectile Dysfunction Drugs Sales by Type (2022-2027) & (M Pill)
Table 81. Japan Erectile Dysfunction Drugs Sales Market Share by Type (2022-2027)
Table 82. Japan Erectile Dysfunction Drugs Sales by Application (2016-2021) & (M Pill)
Table 83. Japan Erectile Dysfunction Drugs Sales Market Share by Application (2016-2021)
Table 84. Japan Erectile Dysfunction Drugs Sales by Application (2022-2027) & (M Pill)
Table 85. Japan Erectile Dysfunction Drugs Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Erectile Dysfunction Drugs Sales (M Pill) by Company (2016-2021)
Table 87. Southeast Asia Erectile Dysfunction Drugs Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Erectile Dysfunction Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Erectile Dysfunction Drugs Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Erectile Dysfunction Drugs Sales by Type (2016-2021) & (M Pill)
Table 91. Southeast Asia Erectile Dysfunction Drugs Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Erectile Dysfunction Drugs Sales by Type (2022-2027) & (M Pill)
Table 93. Southeast Asia Erectile Dysfunction Drugs Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Erectile Dysfunction Drugs Sales by Application (2016-2021) & (M Pill)
Table 95. Southeast Asia Erectile Dysfunction Drugs Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Erectile Dysfunction Drugs Sales by Application (2022-2027) & (M Pill)
Table 97. Southeast Asia Erectile Dysfunction Drugs Sales Market Share by Application (2022-2027)
Table 98. India Erectile Dysfunction Drugs Sales (M Pill) by Company (2016-2021)
Table 99. India Erectile Dysfunction Drugs Sales Market Share by Company (2016-2021)
Table 100. India Erectile Dysfunction Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Erectile Dysfunction Drugs Revenue Market Share by Company (2016-2021)
Table 102. India Erectile Dysfunction Drugs Sales by Type (2016-2021) & (M Pill)
Table 103. India Erectile Dysfunction Drugs Sales Market Share by Type (2016-2021)
Table 104. India Erectile Dysfunction Drugs Sales by Type (2022-2027) & (M Pill)
Table 105. India Erectile Dysfunction Drugs Sales Market Share by Type (2022-2027)
Table 106. India Erectile Dysfunction Drugs Sales by Application (2016-2021) & (M Pill)
Table 107. India Erectile Dysfunction Drugs Sales Market Share by Application (2016-2021)
Table 108. India Erectile Dysfunction Drugs Sales by Application (2022-2027) & (M Pill)
Table 109. India Erectile Dysfunction Drugs Sales Market Share by Application (2022-2027)
Table 110. Eli Lilly Corporation Information
Table 111. Eli Lilly Description and Business Overview
Table 112. Eli Lilly Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million USD), Price (USD/Pill) and Gross Margin (2016-2021)
Table 113. Eli Lilly Erectile Dysfunction Drugs Product
Table 114. Eli Lilly Recent Development
Table 115. Pfizer Corporation Information
Table 116. Pfizer Description and Business Overview
Table 117. Pfizer Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million USD), Price (USD/Pill) and Gross Margin (2016-2021)
Table 118. Pfizer Erectile Dysfunction Drugs Product
Table 119. Pfizer Recent Development
Table 120. Bayer Corporation Information
Table 121. Bayer Description and Business Overview
Table 122. Bayer Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million USD), Price (USD/Pill) and Gross Margin (2016-2021)
Table 123. Bayer Erectile Dysfunction Drugs Product
Table 124. Bayer Recent Development
Table 125. BaiYunShan General Factory Corporation Information
Table 126. BaiYunShan General Factory Description and Business Overview
Table 127. BaiYunShan General Factory Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million USD), Price (USD/Pill) and Gross Margin (2016-2021)
Table 128. BaiYunShan General Factory Erectile Dysfunction Drugs Product
Table 129. BaiYunShan General Factory Recent Development
Table 130. S.K. Chemicals Corporation Information
Table 131. S.K. Chemicals Description and Business Overview
Table 132. S.K. Chemicals Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million USD), Price (USD/Pill) and Gross Margin (2016-2021)
Table 133. S.K. Chemicals Erectile Dysfunction Drugs Product
Table 134. S.K. Chemicals Recent Development
Table 135. Teva Pharma Corporation Information
Table 136. Teva Pharma Description and Business Overview
Table 137. Teva Pharma Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million USD), Price (USD/Pill) and Gross Margin (2016-2021)
Table 138. Teva Pharma Erectile Dysfunction Drugs Product
Table 139. Teva Pharma Recent Development
Table 140. Dong-A ST Corporation Information
Table 141. Dong-A ST Description and Business Overview
Table 142. Dong-A ST Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million USD), Price (USD/Pill) and Gross Margin (2016-2021)
Table 143. Dong-A ST Erectile Dysfunction Drugs Product
Table 144. Dong-A ST Recent Development
Table 145. Metuchen Pharma Corporation Information
Table 146. Metuchen Pharma Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million USD), Price (USD/Pill) and Gross Margin (2016-2021)
Table 147. Metuchen Pharma Description and Business Overview
Table 148. Metuchen Pharma Erectile Dysfunction Drugs Product
Table 149. Metuchen Pharma Recent Development
Table 150. Seoul Pharma Corporation Information
Table 151. Seoul Pharma Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million USD), Price (USD/Pill) and Gross Margin (2016-2021)
Table 152. Seoul Pharma Description and Business Overview
Table 153. Seoul Pharma Erectile Dysfunction Drugs Product
Table 154. Seoul Pharma Recent Development
Table 155. CSBIO. Corporation Information
Table 156. CSBIO. Description and Business Overview
Table 157. CSBIO. Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million USD), Price (USD/Pill) and Gross Margin (2016-2021)
Table 158. CSBIO. Erectile Dysfunction Drugs Product
Table 159. CSBIO. Recent Development
Table 160. Production Base and Market Concentration Rate of Raw Material
Table 161. Key Suppliers of Raw Materials
Table 162. Erectile Dysfunction Drugs Distributors List
Table 163. Erectile Dysfunction Drugs Customers List
Table 164. Erectile Dysfunction Drugs Market Trends
Table 165. Erectile Dysfunction Drugs Market Drivers
Table 166. Erectile Dysfunction Drugs Market Challenges
Table 167. Erectile Dysfunction Drugs Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Erectile Dysfunction Drugs Product Picture
Figure 2. Global Erectile Dysfunction Drugs Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Erectile Dysfunction Drugs Sales Market Share by Application in 2021 & 2027
Figure 6. Hospital Pharmacies Examples
Figure 7. Private Clinics Examples
Figure 8. Retail Pharmacies Examples
Figure 9. E-Commerce (B2B) Examples
Figure 10. E-Commerce (B2C) Examples
Figure 11. Global Erectile Dysfunction Drugs Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Erectile Dysfunction Drugs Sales Growth Rate (2016-2027) & (US$ Million)
Figure 13. Global Erectile Dysfunction Drugs Sales (M Pill) Growth Rate (2016-2027)
Figure 14. Global Erectile Dysfunction Drugs Price Trends Growth Rate (2016-2027) (USD/Pill)
Figure 15. Global Erectile Dysfunction Drugs Revenue Market Share by Region: 2016 VS 2021
Figure 16. Global Erectile Dysfunction Drugs Revenue Market Share by Region: 2021 VS 2027
Figure 17. North America Erectile Dysfunction Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. North America Erectile Dysfunction Drugs Sales (M Pill) Growth Rate (2016-2027)
Figure 19. Europe Erectile Dysfunction Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. Europe Erectile Dysfunction Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 21. China Erectile Dysfunction Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. China Erectile Dysfunction Drugs Sales (Million USD) and Growth Rate (2016-2027)
Figure 23. Japan Erectile Dysfunction Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Japan Erectile Dysfunction Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Erectile Dysfunction Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. Southeast Asia Erectile Dysfunction Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 27. India Erectile Dysfunction Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 28. India Erectile Dysfunction Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 29. Global 5 Largest Erectile Dysfunction Drugs Players Market Share by Revenue in Erectile Dysfunction Drugs: 2016 & 2020
Figure 30. Erectile Dysfunction Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 31. Global Erectile Dysfunction Drugs Revenue Share by Type (2016-2021)
Figure 32. Global Erectile Dysfunction Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 33. Global Erectile Dysfunction Drugs Revenue Share by Application (2016-2021)
Figure 34. Global Erectile Dysfunction Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 35. North America Erectile Dysfunction Drugs Sales Market Share by Type in 2020
Figure 36. North America Erectile Dysfunction Drugs Sales Market Share by Application in 2020
Figure 37. Europe Erectile Dysfunction Drugs Sales Market Share by Type in 2020
Figure 38. Europe Erectile Dysfunction Drugs Sales Market Share by Application in 2020
Figure 39. China Erectile Dysfunction Drugs Sales Market Share by Type in 2020
Figure 40. China Erectile Dysfunction Drugs Sales Market Share by Application in 2020
Figure 41. Japan Erectile Dysfunction Drugs Sales Market Share by Type in 2020
Figure 42. Japan Erectile Dysfunction Drugs Sales Market Share by Application in 2020
Figure 43. Southeast Asia Erectile Dysfunction Drugs Sales Market Share by Type in 2020
Figure 44. Southeast Asia Erectile Dysfunction Drugs Sales Market Share by Application in 2020
Figure 45. India Erectile Dysfunction Drugs Sales Market Share by Type in 2020
Figure 46. India Erectile Dysfunction Drugs Sales Market Share by Application in 2020
Figure 47. Key Raw Materials Price Trend
Figure 48. Manufacturing Cost Structure of Erectile Dysfunction Drugs
Figure 49. Manufacturing Process Analysis of Erectile Dysfunction Drugs
Figure 50. Erectile Dysfunction Drugs Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
世界の勃起不全治療薬市場規模・現状・予測（2021年-2027年） Erectile dysfunction is a very common sexual problem affecting 100 million people worldwide. It is often contributed by neurological disorders, cardiovascular diseases, diabetes, hormonal imbalance and obesity. The incidence of erectile dysfunction is also proportionate to ageing, along with being a…- 勃起不全（ED）薬のグローバル市場調査 2019年 The global Erectile Dysfunction(ED) Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Erectile Dysfunction(ED) Drug volume and value at global level, regional level and company level. From a glob…
- 世界の勃起不全治療市場規模・現状・予測（2021年-2027年） Erectile dysfunction (ED) also known as impotence, refers to problems with achieving and maintaining erections.Currently available treatment for erectile dysfunction is oral therapy, usually with pde-5 inhibitors (sildenafil, tadalafil, avanafil and vardenafil), as well as penis implants, vacuum con…
- 世界の女性性機能障害治療市場規模・現状・予測（2021年-2027年） Sexual dysfunction is difficulty experienced by an individual or a couple during any stage of a normal sexual activity, including physical pleasure, desire, preference, arousal or orgasm. The increasing prevalence of chronic diseases is one of the key factors that will drive the growth of the market…
- 女性用性機能障害治療のグローバル市場：規模・現状・予測2019-2025 Sexual dysfunction is difficulty experienced by an individual or a couple during any stage of a normal sexual activity, including physical pleasure, desire, preference, arousal or orgasm. The increasing prevalence of chronic diseases is one of the key factors that will drive the growth of the market…